Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Anti-HSV-2/HHV-2 gB/Envelope glycoprotein B Recombinant Antibody (SAA2248)


View Antibody details

Anti-HSV-2/HHV-2 gD/Envelope glycoprotein D Antibody (SAA0365)


Antibody System logo
View Antibody details

Anti-HSV-2/HHV-2 gD/Envelope glycoprotein D Recombinant Antibody (SAA0365)


View Antibody details

Anti-HSV1/HHV-1 gD Recombinant Nanobody (G44)


View Antibody details

Anti-HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein) Ankyron


Abcalis logo
View Antibody details

Anti-HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein) Ankyron


Abcalis logo
View Antibody details

Anti-HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein) Ankyron


Abcalis logo
View Antibody details

Anti-HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein) Ankyron


Abcalis logo
View Antibody details

Anti-HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein) Ankyron


Abcalis logo
View Antibody details

Anti-HTLV-1 Glycoprotein 46/gp46 Recombinant Antibody (SAA2372)


View Antibody details